[Analysis of intoxication with novel psychoactive substance (NPS) in Pomeranian region, from January to July 2015]. 2015

Piotr Kabata, and Daria Schetz, and Wojciech Waldman, and Marek Wiergowsk, and Jacek Sein Anand

BACKGROUND During initial months of the year 2015 we observed the increase number of patients intoxicated with NPS in Poland. In our work we analysed the scale of this phenomenon in Pomeranian region. METHODS Study was carried out on period from 1 January 2015 to 31 July 2015. Analysis was based on records derived from Electronic Poison Information Database developed and used on a daily basis on Pomeranian Centre of Toxicology (PCT), data obtained from Centre for Monitoring of Adverse Effects of Medicaments and Chemical Substances based in PCT and on information gathered from patients treated in Pomeranian Centre of Toxicology for NPS intoxication. RESULTS Our study has shown slow, continuous rise in the number of intoxications with NPS in analysed period. The most frequent cause of intoxication were synthetic compounds. 99 cases needed treatment in Clinical Toxicology Unit due to their severe state. The youngest exposed person was 13 y.o., while the oldest was 53 y.o. Mean age was 22.5 y.o. with median 20 years. Majority of intoxications were among males (80.54%). 61.53% of all patients came from Tricity agglomeration. Ethanol was the prevalent coingestant. The most commonly used substance was generic NPS (70.59% of cases), followed by unknowns psychoactive substance (16.29% of cases), herbal mixture (16.29% of cases) and dextrometorphan (5.88% of cases). The study did not find one drug name that would be prevalent over others, with the most frequent commercial name being "Mocarz", found in 4 cases. Most dangerous substances found in NPS were PMA, PMMA, 25C-NBOMe and 251-NBOMe. There were no deaths of patients treated in PCT because of acute intoxication with NPS.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011044 Poland A country in central Europe, east of Germany. The capital is Warsaw. Polish People's Republic,Republic of Poland
D011619 Psychotropic Drugs A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquilizing agents (including the antipsychotics and anti-anxiety agents). Psychoactive Agent,Psychoactive Agents,Psychoactive Drug,Psychopharmaceutical,Psychopharmaceuticals,Psychotropic Drug,Psychoactive Drugs,Agent, Psychoactive,Agents, Psychoactive,Drug, Psychoactive,Drug, Psychotropic,Drugs, Psychoactive,Drugs, Psychotropic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000431 Ethanol A clear, colorless liquid rapidly absorbed from the gastrointestinal tract and distributed throughout the body. It has bactericidal activity and is used often as a topical disinfectant. It is widely used as a solvent and preservative in pharmaceutical preparations as well as serving as the primary ingredient in ALCOHOLIC BEVERAGES. Alcohol, Ethyl,Absolute Alcohol,Grain Alcohol,Alcohol, Absolute,Alcohol, Grain,Ethyl Alcohol
D015198 Designer Drugs Drugs designed and synthesized, often for illegal street use, by modification of existing drug structures (e.g., amphetamines). Of special interest are MPTP (a reverse ester of meperidine), MDA (3,4-methylenedioxyamphetamine), and MDMA (3,4-methylenedioxymethamphetamine). Many drugs act on the aminergic system, the physiologically active biogenic amines. Customized Drug,Customized Drugs,Designer Drug,Drug, Customized,Drug, Designer,Drugs, Customized,Drugs, Designer

Related Publications

Piotr Kabata, and Daria Schetz, and Wojciech Waldman, and Marek Wiergowsk, and Jacek Sein Anand
July 2014, Journal of forensic and legal medicine,
Piotr Kabata, and Daria Schetz, and Wojciech Waldman, and Marek Wiergowsk, and Jacek Sein Anand
May 2014, Medizinische Klinik, Intensivmedizin und Notfallmedizin,
Piotr Kabata, and Daria Schetz, and Wojciech Waldman, and Marek Wiergowsk, and Jacek Sein Anand
January 2020, Frontiers in psychiatry,
Piotr Kabata, and Daria Schetz, and Wojciech Waldman, and Marek Wiergowsk, and Jacek Sein Anand
January 2021, Frontiers in psychiatry,
Piotr Kabata, and Daria Schetz, and Wojciech Waldman, and Marek Wiergowsk, and Jacek Sein Anand
December 2019, Medical science monitor : international medical journal of experimental and clinical research,
Piotr Kabata, and Daria Schetz, and Wojciech Waldman, and Marek Wiergowsk, and Jacek Sein Anand
July 2019, Clinical toxicology (Philadelphia, Pa.),
Piotr Kabata, and Daria Schetz, and Wojciech Waldman, and Marek Wiergowsk, and Jacek Sein Anand
January 2018, Drug testing and analysis,
Piotr Kabata, and Daria Schetz, and Wojciech Waldman, and Marek Wiergowsk, and Jacek Sein Anand
February 2018, Drug testing and analysis,
Piotr Kabata, and Daria Schetz, and Wojciech Waldman, and Marek Wiergowsk, and Jacek Sein Anand
March 2021, Forensic science international,
Piotr Kabata, and Daria Schetz, and Wojciech Waldman, and Marek Wiergowsk, and Jacek Sein Anand
September 2019, Journal of analytical toxicology,
Copied contents to your clipboard!